Norwalk virus: how infectious is it? PFM Teunis, CL Moe, P Liu, S E. Miller, L Lindesmith, RS Baric, ... Journal of medical virology 80 (8), 1468-1476, 2008 | 1431 | 2008 |
Human susceptibility and resistance to Norwalk virus infection L Lindesmith, C Moe, S Marionneau, N Ruvoen, XI Jiang, L Lindblad, ... Nature medicine 9 (5), 548-553, 2003 | 1348 | 2003 |
Mechanisms of GII. 4 norovirus persistence in human populations LC Lindesmith, EF Donaldson, AD LoBue, JL Cannon, DP Zheng, J Vinje, ... PLoS medicine 5 (2), e31, 2008 | 692 | 2008 |
Durability of mRNA-1273 vaccine–induced antibodies against SARS-CoV-2 variants A Pegu, SE O’Connell, SD Schmidt, S O’Dell, CA Talana, L Lai, J Albert, ... Science 373 (6561), 1372-1377, 2021 | 543 | 2021 |
Viral shape-shifting: norovirus evasion of the human immune system EF Donaldson, LC Lindesmith, AD LoBue, RS Baric Nature Reviews Microbiology 8 (3), 231-241, 2010 | 374 | 2010 |
Norovirus infectivity in humans and persistence in water SR Seitz, JS Leon, KJ Schwab, GM Lyon, M Dowd, M McDaniels, ... Applied and environmental microbiology 77 (19), 6884-6888, 2011 | 358 | 2011 |
Norovirus pathogenesis: mechanisms of persistence and immune evasion in human populations EF Donaldson, LC Lindesmith, AD Lobue, RS Baric Immunological reviews 225 (1), 190-211, 2008 | 355 | 2008 |
Binding of Norwalk virus-like particles to ABH histo-blood group antigens is blocked by antisera from infected human volunteers or experimentally vaccinated mice PR Harrington, L Lindesmith, B Yount, CL Moe, RS Baric Journal of virology 76 (23), 12335-12343, 2002 | 353 | 2002 |
Cellular and humoral immunity following Snow Mountain virus challenge L Lindesmith, C Moe, J LePendu, JA Frelinger, J Treanor, RS Baric Journal of virology 79 (5), 2900-2909, 2005 | 327 | 2005 |
Immunogenetic mechanisms driving norovirus GII. 4 antigenic variation LC Lindesmith, M Beltramello, EF Donaldson, D Corti, J Swanstrom, ... PLoS pathogens 8 (5), e1002705, 2012 | 291 | 2012 |
Norovirus GII. 4 strain antigenic variation LC Lindesmith, EF Donaldson, RS Baric Journal of virology 85 (1), 231-242, 2011 | 204 | 2011 |
Emergence of new pandemic GII. 4 Sydney norovirus strain correlates with escape from herd immunity K Debbink, LC Lindesmith, EF Donaldson, V Costantini, M Beltramello, ... The Journal of infectious diseases 208 (11), 1877-1887, 2013 | 183 | 2013 |
Emergence of a norovirus GII. 4 strain correlates with changes in evolving blockade epitopes LC Lindesmith, V Costantini, J Swanstrom, K Debbink, EF Donaldson, ... Journal of virology 87 (5), 2803-2813, 2013 | 175 | 2013 |
Genetic mapping of a highly variable norovirus GII. 4 blockade epitope: potential role in escape from human herd immunity K Debbink, EF Donaldson, LC Lindesmith, RS Baric Journal of virology 86 (2), 1214-1226, 2012 | 175 | 2012 |
Multivalent norovirus vaccines induce strong mucosal and systemic blocking antibodies against multiple strains AD LoBue, L Lindesmith, B Yount, PR Harrington, JM Thompson, ... Vaccine 24 (24), 5220-5234, 2006 | 173 | 2006 |
Chimeric spike mRNA vaccines protect against Sarbecovirus challenge in mice DR Martinez, A Schäfer, SR Leist, G De la Cruz, A West, ... Science 373 (6558), 991-998, 2021 | 163 | 2021 |
Heterotypic humoral and cellular immune responses following Norwalk virus infection LC Lindesmith, E Donaldson, J Leon, CL Moe, JA Frelinger, RE Johnston, ... Journal of virology 84 (4), 1800-1815, 2010 | 162 | 2010 |
Norovirus immunity and the great escape K Debbink, LC Lindesmith, EF Donaldson, RS Baric Public Library of Science 8 (10), e1002921, 2012 | 161 | 2012 |
Broad blockade antibody responses in human volunteers after immunization with a multivalent norovirus VLP candidate vaccine: immunological analyses from a phase I clinical trial LC Lindesmith, MT Ferris, CW Mullan, J Ferreira, K Debbink, J Swanstrom, ... PLoS medicine 12 (3), e1001807, 2015 | 147 | 2015 |
Vaccination-induced herd immunity: successes and challenges ML Mallory, LC Lindesmith, RS Baric Journal of Allergy and Clinical Immunology 142 (1), 64-66, 2018 | 137 | 2018 |